American Flag

Commercial Litigation and Damages

Financial Asset and Business Valuation

Financial Asset and Business Valuation

NERA economists help clients establish a fair and accurate valuation of a business or financial asset. Business valuation depends on financial forecasting and analysis -- but that is only the beginning. To make sound forecasts, it is important to understand the dynamics of the marketplace. This is the hallmark of NERA's approach -- one that has been successfully used by business owners and attorneys in litigation, and investment bankers/venture capitalists interested in acquiring a real measure of business value.  Similarly, financial asset valuation requires going beyond just plugging numbers into an equation, but also recognizing whether a standard financial model is appropriate for the financial asset being valued.

Name Title Location Phone Email
Dr. Sumanth Addanki Managing Director White Plains, NY +1 914 448 4060 sumanth.addanki@nera.com
Lucy P. Allen Managing Director New York City +1 212 345 5913 lucy.allen@nera.com
Oscar Arnedillo Managing Director Madrid +34 91 521 0020 oscar.arnedillo@nera.com
Dr. Vinita Juneja Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice 		New York City
London
Toronto 		+1 212 345 3148
+44 20 7659 8618
+1 416 868 7314 		vinita.juneja@nera.com
Dr. Jeff D. Makholm Managing Director Boston +1 617 927 4540 jeff.makholm@nera.com
Dr. Denise Neumann Martin Managing Director Miami +1 212 345 5296 denise.martin@nera.com
Dr. Faten Sabry Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair 		New York City
London 		+1 212 345 3285
+44 20 7659 8618 		faten.sabry@nera.com
Bradley A. Heys Director Toronto
New York City 		+1 416 868 7312
+1 212 345 2691 		brad.heys@nera.com
Daniel Radov Director London +44 20 7659 8744 daniel.radov@nera.com
Dr. Ling Ling Ang Associate Director New York City
Washington, DC 		+1 212 345 5409
+1 202 466 9259 		lingling.ang@nera.com
Dr. Airat Chanyshev Associate Director New York City +1 212 345 7336 airat.chanyshev@nera.com
Dr. Jordan Milev Associate Director New York City +1 212 345 5516 jordan.milev@nera.com
Bryan Ray Associate Director White Plains, NY +1 914 448 4004 bryan.ray@nera.com
Mark L. Berenblut Affiliated Consultant Toronto
New York City
London 		+1 416 868 7311
+1 917 475 0020
+44 20 3769 1096 		mark.berenblut.affiliate@nera.com
Dr. Andrew Carron Affiliated Consultant New York City
London 		+1 212 345 5407
+44 20 7659 8500 		andrew.carron.affiliate@nera.com
Dr. Alan Cox Affiliated Consultant San Francisco +1 415 291 1000 alan.cox.affiliate@nera.com
Dr. James Jordan Affiliated Consultant Washington, DC +1 202 466 9263 james.jordan.affiliate@nera.com
Dr. Michael Rosenzweig Affiliated Consultant Washington, DC +1 202 466 9231 michael.rosenzweig.affiliate@nera.com
Title Type Author
Recent Trends in Securities Class Action Litigation: H1 2020 Update Report Janeen McIntosh and Svetlana Starykh
Snapshot of Recent Trends in Asbestos Litigation: 2020 Update Report Mary Elizabeth C. Stern and Lucy P. Allen
Hey Google: When Did People Stop Going to Work? White Paper By Dr. Faten Sabry, Linh Nguyen, and Aakash Bhalothia
Economic and Financial Analyses in Australian Securities Litigation in the Wake of TP... White Paper Dr. David Tabak and Dr. Will Taylor
Recent Trends in Securities Class Action Litigation: Q1 2020 Update White Paper Janeen McIntosh.and Svetlana Starykh
How Are Different Types of Stocks Weathering COVID-19? Published Article By Dr. Jordan Milev
Analyzing Value Changes between Signing and Closing in Delaware Appraisal Actions White Paper Jonathan Polonsky
Trends in Canadian Securities Class Actions: 2019 Update Report Bradley A. Heys, Robert Patton, Jielei Mao
Recent Trends in Securities Class Action Litigation: 2019 Full-Year Review Report Janeen McIntosh and Svetlana Starykh
Fed's Real-Time Payments Idea Presents Risks, Challenges Published Article Ling Ling Ang, with Judy Mok